rebuffed EU antitrust charges of making an illegal deal with rival Cephalon to delay selling a cheaper generic version of the latter's sleep... ...http://www.business-standard.com/article/reuters/teva-rebuffs-eu-pay-for-delay-charge-at-hearing-118031400043_1.html
CNBC-TV18’s Archana Shukla caught up with Nilesh Gupta on the sidelines of the pharma forum and asked him about the generic pharma market. ...http://www.moneycontrol.com/news/business/concern-is-that-established-players-like-sandoz-tevamoving-out-lupin_10568021.html
NEW YORK (Reuters) - Warren Buffett had a Valentine’s Day surprise for investors in Teva Pharmaceutical Industries Ltd. ...http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/B-rXLHRplk4/backstory-warren-buffetts-valentines-day-surprise-for-investors-idINKCN1G0141
TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries said on Tuesday it had anticipated and planned for a second generic competitor to... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/ASPx65viBK8/teva-planned-for-second-generic-copaxone-to-enter-market-in-2018-idINKBN1FX1LA
The US unit of Indivior has filed patent lawsuits against generic filers such as Dr Reddy’s, Actavis, Par, Alvogen and Teva for infringement of... ...http://www.moneycontrol.com/news/business/dr-reddy39s-may-face-delayslaunchgsuboxone-as-indivior-throws-new-patent-challenge_10481061.html
The company was formed way back in...